Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 11 -20 of 285 Show results per page	View Search Criteria \| Help With Results

Last Modified: 7/17/2007 First Published: 1/1/2001


11.		Phase III Randomized Study of Fluorouracil With Leucovorin Calcium and Either Irinotecan or Oxaliplatin in Patients With Unresectable Metastatic Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				Other				MRC-CR08-FOCUS EU-20038, ISRCTN79877428, NCT00008060

Last Modified: 1/16/2008 First Published: 3/1/2001


12.		Phase III Randomized Study of Bevacizumab (rhuMAb VEGF) With Fluorouracil and Leucovorin Calcium With or Without Irinotecan in Patients With Metastatic Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				Pharmaceutical / Industry				GENENTECH-AVF2107g UCLA-0008022, NCT00012233

Last Modified: 12/19/2007 First Published: 3/1/2001


13.		Phase III Randomized Study of Irinotecan With or Without Oxaliplatin in Patients With Metastatic Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				Pharmaceutical / Industry				SANOFI-EFC4585 NCT00012389

Last Modified: 3/29/2004 First Published: 4/1/2001


14.		Phase III Randomized Study of Regional and Systemic Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Patients With Unresectable Colorectal Cancer Metastatic to the Liver

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI				NCI-01-C-0093 NCT00020501

Last Modified: 9/1/2001 First Published: 7/1/2001


15.		Phase III Randomized Study of Fluorouracil, Leucovorin Calcium, and Irinotecan With or Without SU5416 in Patients With Previously Untreated Metastatic Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI, Pharmaceutical / Industry				UCLA-001003701 SUGEN-SU5416.035, NCI-G01-1980, NCT00021281

Last Modified: 11/15/2004 First Published: 9/1/2001


16.		Phase III Randomized Study of Irinotecan, Fluorouracil, and Leucovorin Calcium With or Without Hepatic Chemoembolization in Patients With Adenocarcinoma of the Colon or Rectum Metastatic to the Liver

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				18 and over				NCI				ACRIN-6655 NCT00023868, ACRIN-6655

Last Modified: 7/17/2008 First Published: 11/1/2001


17.		Phase III Randomized Study of Adjuvant Fluorouracil and Leucovorin Calcium With or Without Irinotecan in Patients With Resected Stage III Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 to 75				Pharmaceutical / Industry				RP-64174-V-307 EORTC-40993, PETACC-3, NCT00026273

Last Modified: 6/6/2008 First Published: 9/1/2002


18.		Phase III Randomized Study of Cisplatin and Irinotecan Versus Cisplatin and Etoposide in Patients With Extensive Stage Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI				SWOG-S0124 NCCTG-S0124, CALGB-S0124, S0124, NCT00045162

Last Modified: 12/12/2007 First Published: 6/23/2003


19.		Phase III Randomized Study of Irinotecan and Capecitabine Versus Irinotecan, Leucovorin Calcium, and Fluorouracil With Versus Without Celecoxib in Patients With Metastatic Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				Other				EORTC-40015 NCT00064181

Last Modified: 8/4/2006 First Published: 8/24/2003


20.		Phase III Randomized Study of Adjuvant Irinotecan, Fluorouracil, and Leucovorin Calcium Versus Oxaliplatin, Fluorouracil, and Leucovorin Calcium Versus Fluorouracil and Leucovorin Calcium in Patients With Stage II or III Rectal Cancer Receiving Combined Radiotherapy and Fluorouracil Either Preoperatively or Postoperatively

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI				ECOG-E3201 E3201, NCT00068692

Select All on One Page


					< Previous 1 2 3 4 5 Next >

| | | | | | | |

A Service of the National Cancer Institute